Infertility Treatment Devices & Equipment Market Expected To Encourage Expansion At CAGR Of 9.3% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.
San Francisco, 9 August 2019: The Report Infertility Treatment Devices & Equipment Market Size, Share & Trends Analysis Report By Type (Ovum Aspiration Pumps, Sperm Separation Devices), By End Use, By Region, And Segment Forecasts, 2019 – 2026
The global infertility treatment devices and equipment market size is expected to reach USD 420.7 million by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.3% during the forecast period. According to the United Nations (UN), the global fertility rate is expected to decline to 2.4 births per woman by 2030 and 2.2 births per woman by 2050. Currently, 46% of the global population lives in countries with low levels of fertility. Another 46% population lives in countries with intermediate fertility and the remaining 8% population lives in countries with high fertility.
Demand for Assisted Reproductive Technology (ARTs) is growing due to growth in infertility rate across the globe. The patients are offered several options for the infertility treatment depending on the causes. Technological advancements in developing regions offer promising growth for fertility clinics, hospitals, and device manufacturers to expand the market presence. Healthcare facilities specializing in ART treatments are required to obtain a license from the respective authorities present in the country.
Availability of various reimbursement schemes in developed regions is likely to drive growth of the market in the forthcoming years. For instance, the Singapore government offers around 75% co-funding for various assisted reproductive treatments. The Ontario government had announced a fertility program worth USD 50 million to cover the treatment of 5,000 people in 2016.
Key players operating in the infertility treatment devices and equipment market are adopting strategies such as acquisitions and partnerships to strengthen their presence in other regional markets. For instance, Vitrolife entered into an agreement to acquire OCTAX Microscience GmbH in 2016. The company strengthened its position in the IVF market by the expansion of its product portfolio through this acquisition.
Access Research Report of Infertility Treatment Devices & Equipment Market @ www.grandviewresearch.com/industry-analysis/infertility-treatment-devices-equipment-market
Further key findings from the study suggest:
Grand View Research has segmented the global infertility treatment devices & equipment market based on type, end use, and region:
Infertility Treatment Devices and Equipment Type Outlook (Revenue, USD Million, 2015 - 2026)
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
The global infertility treatment devices and equipment market size is expected to reach USD 420.7 million by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.3% during the forecast period. According to the United Nations (UN), the global fertility rate is expected to decline to 2.4 births per woman by 2030 and 2.2 births per woman by 2050. Currently, 46% of the global population lives in countries with low levels of fertility. Another 46% population lives in countries with intermediate fertility and the remaining 8% population lives in countries with high fertility.
Demand for Assisted Reproductive Technology (ARTs) is growing due to growth in infertility rate across the globe. The patients are offered several options for the infertility treatment depending on the causes. Technological advancements in developing regions offer promising growth for fertility clinics, hospitals, and device manufacturers to expand the market presence. Healthcare facilities specializing in ART treatments are required to obtain a license from the respective authorities present in the country.
Availability of various reimbursement schemes in developed regions is likely to drive growth of the market in the forthcoming years. For instance, the Singapore government offers around 75% co-funding for various assisted reproductive treatments. The Ontario government had announced a fertility program worth USD 50 million to cover the treatment of 5,000 people in 2016.
Key players operating in the infertility treatment devices and equipment market are adopting strategies such as acquisitions and partnerships to strengthen their presence in other regional markets. For instance, Vitrolife entered into an agreement to acquire OCTAX Microscience GmbH in 2016. The company strengthened its position in the IVF market by the expansion of its product portfolio through this acquisition.
Access Research Report of Infertility Treatment Devices & Equipment Market @ www.grandviewresearch.com/industry-analysis/infertility-treatment-devices-equipment-market
Further key findings from the study suggest:
- Sperm separation devices led the type segment in terms of revenue share in 2018. These devices are used in assisted reproductive treatments such as IVF and artificial insemination to purify the semen samples
- Imaging systems is expected to be the fastest growing segment over the forecast period as time-lapse imaging systems prevent embryos from getting disturbed in the culture during their assessment, eliminating manual handling
- Fertility clinics led the end use segment in 2018, in terms of revenue share. These clinics offer couple counselling and plan treatments based on the causes and severity of their infertility
- Europe led the overall market in terms of revenue in 2018 owing to the constantly declining fertility rate in the region. Increasing number of couples opting for ARTs along with growing medical tourism in some European countries is further fueling the growth
- Some of the key players operating in the infertility treatment devices and equipment market are The Cooper Companies, Inc.; Hamilton Thorne, Inc.; Cook; Vitrolife; and DxNow, Inc. among others
Grand View Research has segmented the global infertility treatment devices & equipment market based on type, end use, and region:
Infertility Treatment Devices and Equipment Type Outlook (Revenue, USD Million, 2015 - 2026)
- Ovum Aspiration Pumps
- Sperm Separation Devices
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Cryosystems
- Imaging Systems
- Microscopes
- Others
- Fertility Clinics
- Hospitals & Other Healthcare Facilities
- Clinical Research Institutes
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Comments
Post a Comment